Insmed's Total Assets for the quarter that ended in Dec. 2024 was $2,025.2 Mil.
Warning Sign:
If a company builds assets at 20% a year, faster than its revenue growth rate of 7.5% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, Insmed's average Total Assets Growth Rate was 7.60% per year.
During the past 3 years, the average Total Assets Growth Rate was 3.90% per year.
During the past 5 years, the average Total Assets Growth Rate was 20.00% per year.
During the past 10 years, the average Total Assets Growth Rate was 30.10% per year.
During the past 13 years, Insmed's highest 3-Year average Total Assets Growth Rate was 207.90%. The lowest was -75.60%. And the median was 13.70%.
Total Assets is connected with ROA %. Insmed's annualizedROA % for the quarter that ended in Dec. 2024 was -46.21%. Total Assets is also linked to Revenue through Asset Turnover. Insmed's Asset Turnover for the quarter that ended in Dec. 2024 was 0.05.
Insmed Total Assets Historical Data
The historical data trend for Insmed's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Insmed's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note:
The Net Income data used here is four times the quarterly (Dec. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Insmed's Asset Turnover for the quarter that ended in Dec. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Insmed Total Assets Related Terms
Thank you for viewing the detailed overview of Insmed's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
INSM has been successfully added to your 